Want to join the conversation?
The cornerstone of $STJ's heart failure program is the CardioMEMS technology that helps reduce heart failure re-admission rates for eligible Medicare heart failure patients by as much as 78%. $STJ eventually expects CardioMEMS product line to become standard-of-care and to be able to generate more than $1Bil in revenue.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?